Green Planet Bioengineering Co (Green Planet Bioengineering Co) Market Cap : $0.00 Mil (As of May. 12, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Green Planet Bioengineering Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Green Planet Bioengineering Co's share price for the quarter that ended in Dec. 2023 was $0.061. Green Planet Bioengineering Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 20.01 Mil. Therefore, Green Planet Bioengineering Co's market cap for the quarter that ended in Dec. 2023 was $1.22 Mil.

Green Planet Bioengineering Co's quarterly market cap declined from Jun. 2023 ($22.01 Mil) to Sep. 2023 ($17.01 Mil) and declined from Sep. 2023 ($17.01 Mil) to Dec. 2023 ($1.22 Mil).

Green Planet Bioengineering Co's annual market cap increased from Dec. 2021 ($3.60 Mil) to Dec. 2022 ($48.22 Mil) but then declined from Dec. 2022 ($48.22 Mil) to Dec. 2023 ($1.22 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Green Planet Bioengineering Co's Enterprise Value for Today is $0.00 Mil.

Green Planet Bioengineering Co Market Cap Historical Data

The historical data trend for Green Planet Bioengineering Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Planet Bioengineering Co Market Cap Chart

Green Planet Bioengineering Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

0.80

0.86

3.60

48.22

1.22

Green Planet Bioengineering Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial															48.22	6.52	22.01	17.01	1.22

Competitive Comparison of Green Planet Bioengineering Co's Market Cap

For the Shell Companies subindustry, Green Planet Bioengineering Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Green Planet Bioengineering Co's Market Cap Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Green Planet Bioengineering Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Green Planet Bioengineering Co's Market Cap falls into.

Green Planet Bioengineering Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Green Planet Bioengineering Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$0.061	*	20.0064
	=	$1.22

Green Planet Bioengineering Co's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	$0.061	*	20.0064
	=	$1.22

Green Planet Bioengineering Co (OTCPK:GPLB) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Green Planet Bioengineering Co Market Cap Related Terms

Thank you for viewing the detailed overview of Green Planet Bioengineering Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Green Planet Bioengineering Co (Green Planet Bioengineering Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Green Planet Bioengineering Co Ltd (OTCPK:GPLB) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

20807 Biscayne Boulevard, Suite 203, Aventura, FL, USA, 33180

Website

http://www.greenplanetbio.com.cn

Green Planet Bioengineering Co Ltd is a shell company.

Executives

Shanyan Ou	director, officer: VP of Sales	18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Jian Chen	director, officer: Chief Scientist	18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Jianrong Zheng	director	18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Zhao	10 percent owner, officer: CHIEF EXECUTIVE OFFICER	18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Yan Zhen	10 percent owner	18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Cris Neely	director, 10 percent owner, officer: President	18851 NE 29TH AVENUE, SUITE 700, AVENTURA CA 33180
Mondo Management Corp.	10 percent owner	61 BROADWAY, NEW YORK NY 10006
Gregory Sichenzia	director, 10 percent owner	SICHENZIA ROSS FRIEDMAN FERENCE LLP, 1065 AVENUE OF THE AMERICAS, 21ST FLOOR, NEW YORK NY 10018
Darrin M Ocasio	director, 10 percent owner, officer: President	C/O MONDO ACQUISITION II, 61 BROADWAY, 32ND FLOOR, NEW YORK NY 10006
Michael H Ference	director, 10 percent owner, officer: Secretary	C/O MONDO ACQUISITION II, 61 BROADWAY, 32ND FLOOR, NEW YORK NY 10006

Green Planet Bioengineering Co (Green Planet Bioengineering Co) Headlines

No Headlines